•  
  •  
  •  
  •  

2023-06-03 06:02:07

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Asahi SongwonColors Limited reports Q4FY23 Results
  • Lemon Tree Hotels launches two new hotels - one each in Agra and Bhopal
  • Hero MotoCorp launches new range of 100cc motorcycle - the HF Deluxe
  • USFDA inspection at Zydus' animal health drug manufacturing facility at SEZ, Ahmedabad
  • Cravatex Limited releases mortgage on properties

Keywords Selected:  Capsules

Stock Report

  • Natural Capsules Ltd recommends dividend of Rs. 0.10
  • Natural Capsules Ltd consolidated Q4FY23 net profit slides to Rs. 1.79 crore
  • Granules India Limited Received ANDA Approval for Venlafaxine ER Capsules
  • Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules, 0.5 g and 1 g
  • Zydus receives Final Approval from the USFDA for Loperamide Hydrochloride Capsules USP, 2 mg
  • Lupin receives tentative approval from U.S. FDA for Valbenazine Capsules
  • Zydus receives Final Approval from the USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg
  • Zydus receives final Approval from the USFDA for Doxepin Hydrochloride Capsules USP, 150 mg
  • Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP
  • NATCO launches additional strengths for the Generic Version of Revlimid® in USA
  • Eugia Pharma Specialities Ltd receives USFDA final approval Lenalidomide Capsules
  • Alembic Pharmaceuticals gets USFDA final approval for Prazosin Hydrochloride Capsules
  • Zydus receives final approval from the USFDA for Lenalidomide Capsules, 2.5 mg and 20 mg
  • Natural Capsules Ltd's holding in Natural Biogenex Pvt Ltd to 89.99%
  • NATCO launches generic Pomalidomide Capsules in Canada
  • Alembic Pharmaceuticals receives USFDA Tentative Approval for Acalabrutinib Capsules, 100 mg
  • Zydus receives tentative approval from the USFDA for Levomilnacipran Extended-Release Capsules
  • Zydus launches Topiramate Extended-Release Capsules
  • Alembic Pharmaceuticals announces its first product approval from its Formulation Division IV, Jarod Facility
  • Glenmark Pharmaceuticals receives ANDA approval for Nicardipine Hydrochloride Capsules, 20 mg and 30 mg
  • Zydus receives two final approvals from the USFDA for Silodosin capsules and Pregabalin capsules
  • Zydus receives final approval from the USFDA for Topiramate Extended-Release Capsules
  • Natural Capsules' subsidiary Natural Biogenex completes its maiden fund-raise of ₹ 18.75 Crores
  • Alembic Pharmaceuticals receives USFDA Final Approval for Cyclophosphamide Capsules, 25 mg and 50 mg

Latest Post

  • Asahi SongwonColors Limited reports Q4FY23 Results
  • Lemon Tree Hotels launches two new hotels - one each in Agra and Bhopal
  • Hero MotoCorp launches new range of 100cc motorcycle - the HF Deluxe
  • USFDA inspection at Zydus' animal health drug manufacturing facility at SEZ, Ahmedabad
  • Cravatex Limited releases mortgage on properties


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2022